FREE SHIPPING ON ORDERS OVER $150

glutathione drug release responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics | Discover Oncology Redox-Responsive Cross-Linking of Polycarbonate Nanomedicines

$26.13

Quantity
- +
Description

La Rev medecine interne

glutathione drug release responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics | Discover Oncology Redox-Responsive Cross-Linking of Polycarbonate Nanomedicines

The evidence for this is provided by evaluating the liver function biomarkers, CYP2E1 gene expression, iron overload, oxidative stress, SIRT-1 expression and hepatic architecture damage associated with APAP overdose

glutathione drug release responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics | Discover Oncology Redox-Responsive Cross-Linking of Polycarbonate Nanomedicines

Ferguson LR, Browning BL, Huebner C, Petermann I, Shelling AN, Demmers P, McCulloch A, Gearry RB, Barclay ML, Philpott M: Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population

glutathione drug release responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics | Discover Oncology Redox-Responsive Cross-Linking of Polycarbonate Nanomedicines

10.3389/fmolb.2022.835976 45 FengY.EganB.WangJ

glutathione drug release responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics | Discover Oncology Redox-Responsive Cross-Linking of Polycarbonate Nanomedicines

You may also like

Frontiers

US$ 20.16

4.0 (8 reviews)

recommand products